Concentrix (CNXC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
13 Feb, 2026Executive summary
The 2026 Annual Meeting will be held virtually on March 25, 2026, with voting available online, by phone, mail, or during the meeting for shareholders of record as of January 27, 2026.
2025 revenue reached $9.8 billion, up 2.2% year-over-year, with $258 million returned to shareholders via repurchases and dividends, and net indebtedness reduced by $184 million.
The company was recognized for sustainability and workplace excellence, and continued to invest in technology and business transformation.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of nine directors, (2) ratification of Ernst & Young LLP as auditor, (3) advisory approval of executive compensation, and (4) amendment to the 2020 Stock Incentive Plan to increase shares available for issuance.
No other shareholder proposals were received for the meeting.
Board of directors and corporate governance
The board consists of nine nominees, 78% of whom are independent and 78% represent gender and/or racial/ethnic diversity.
Average board tenure is 3.9 years and average age is 60.9 years.
Board committees include Audit, Compensation, Nominating and Governance, and Executive, with all but the Executive Committee composed solely of independent directors.
The board conducts annual self-evaluations and maintains stock ownership guidelines for directors.
Shareholder engagement included over 250 investor meetings in 2025, covering financial performance, innovation, compensation, and governance.
Latest events from Concentrix
- AI-driven IX suite accelerates margin growth and cash flow, supporting debt reduction and future value.CNXC
Canaccord Genuity's 46th Annual Growth Conference - Q2 revenue up 1.9% with record cash flow, but margins fell amid restructuring costs.CNXC
Q2 2026 - All voting items, including director elections and stock plan amendment, were approved.CNXC
AGM 2026 - Revenue up 5.4% to $2.5B, but margins and net income declined despite strong AI-driven growth.CNXC
Q1 2026 - Supplement clarifies voting rules for a key stock incentive plan amendment proposal.CNXC
Proxy Filing - Key votes include director elections, auditor ratification, and stock plan amendment.CNXC
Proxy Filing - Record revenue and cash flow in 2025, with 2026 growth expected despite a goodwill impairment.CNXC
Q4 2025 - Q2 revenue up 47.4% to $2.38B; guidance raised despite net income decline on higher costs.CNXC
Q2 2024 - FY25 guidance projects modest revenue growth, margin expansion, and higher free cash flow.CNXC
Q4 2024